At the time of writing, Cardiol Therapeutics Inc [CRDL] stock is trading at $1.13, up 9.71%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CRDL shares have lost -16.30% over the last week, with a monthly amount drifted -15.04%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cardiol Therapeutics Inc [NASDAQ: CRDL] stock has seen the most recent analyst activity on June 02, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $9. Previously, Rodman & Renshaw started tracking the stock with Buy rating on January 28, 2025, and set its price target to $7. On June 26, 2024, ROTH MKM initiated with a Buy rating and assigned a price target of $10 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $9 on April 22, 2024.
For the past year, the stock price of Cardiol Therapeutics Inc fluctuated between $0.77 and $2.63. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Cardiol Therapeutics Inc [NASDAQ: CRDL] shares were valued at $1.13 at the most recent close of the market. An investor can expect a potential return of 607.96% based on the average CRDL price forecast.
Analyzing the CRDL fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.41, Equity is -2.1 and Total Capital is -1.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0500 points at the first support level, and at 0.9700 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1800, and for the 2nd resistance point, it is at 1.2300.
Ratios To Look Out For
It is important to note that Cardiol Therapeutics Inc [NASDAQ:CRDL] has a current ratio of 3.26. Also, the Quick Ratio is 3.26, while the Cash Ratio stands at 3.01.
